Novavax filed COVID-19 vaccine for provisional approval in New Zealand
On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…
On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS (Comisión Federal para la…
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…
On Jun. 14, 2021, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against…
On Mar. 24, 2021, scientists from Washington University School of Medicine in St. Louis announced they had identified…
On Oct. 8, 2020, a clinical trial to test the safety, tolerability and efficacy of a combination treatment…
On Sept. 17, 2020, Genentech, a member of the Roche Group announced that the Phase III EMPACTA study…
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
On Aug. 9, 2020, OpGen announced that it had commenced marketing and promotion, on a non-exclusive basis, of…
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
On Jun. 3, 2012, U.S. Department of Agriculture (USDA) scientists and their colleagues have published the most comprehensive…
On May 28, 2010, the National Institute for Occupational Safety and Health (NIOSH) received a request for a…
On May 14, 1993, the New Mexico Department of Health (NMDOH) reported it was notified by the Office…
In 1978, the etiologic agent of Korean Hemerologic fever was isolated from small infected field rodent Apodemus agrarius…
On Sept. 21, 1960, U.S. Food and Drug Administration (FDA) officials announced the last remaining major source of…
In 1933, the New World Screwworm (NWS) was first documented as a significant problem in the Southeast following…